DHR-PB

Danaher Corporation [DHR-PB] Stock Forecast

Q: What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock, located in Washington of Dc and trading under the symbol DHR-PB

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

DHR-PB Stock Summary

Earnings have grown 6.85% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

The Moving Average Convergence Divergence (MACD) for DHR-PB recently turned positive (within last 10 days).

DHR-PB's dividend payments are well covered by cash flows with cash payout ratio of 11.89%.

Earnings are expected to fall -100% next year

Unstable dividend track record

EPS has been decreasing for the past 3 quarters (Quarter statements)

Profit margins (0.22%) are lower than the previous year (0.23%)

DHR-PB has less than 1 year of cash runway

In the News

DHR-PB Financial details

Company Rating

Strong Buy

Market Cap

916.76B

Income

6.36B

Revenue

30.36B

Book val./share

70.14

Cash/share

11.63

Dividend

1.04

Dividend %

0.42%

Employees

79K

Optionable

Shortable

Yes

Earnings

31 Mar 2023

P/E

26.13

Forward P/E

PEG

-152.77

P/S

5.93

P/B

3.52

P/C

108.45

P/FCF

25.05

Quick Ratio

1.34

Current Ratio

1.89

Debt / Equity

0.38

LT Debt / Equity

0.35

EPS (TTM)

8.62

EPS next Y

EPS next Q

EPS this Y

11.74%

EPS next Y

EPS next 5Y

EPS last 5Y

20.99%

Revenue last 5Y

9.61%

Revenue Q/Q

-0.14%

EPS Q/Q

-23.47%

SMA20

SMA50

SMA100

Inst Own

0.19%

Inst Trans

0.79%

ROA

ROE

14%

ROC

0.1%

Gross Margin

60%

Oper. Margin

25%

Profit Margin

22%

Payout

12%

Shs Outstand

726.86M

Shs Float

649.15M

Target Price

52W Range

1199.99-1521.85

52W High

-17.08%

52W Low

+5.19%

RSI

Rel Volume

11.75

Avg Volume

12.97K

Volume

152.33K

Perf Week

0.84%

Perf Month

Perf Quarter

Perf Half Y

0.08%

Beta

0.80173

Volatility

7.21%, 8.87%

Prev Close

Price

1261.26

Change

-0.21%

DHR-PB Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	28.39	25.05	31.55	41.22	43.4
Net income per share	3.78	4.21	5.16	9	9.94
Operating cash flow per share	5.74	5.53	8.79	11.7	11.75
Free cash flow per share	4.91	4.64	7.67	9.89	10.16
Cash per share	1.12	27.85	8.55	3.62	8.27
Book value per share	40.27	42.34	56.31	63.21	69.07
Tangible book value per share	-13.35	-3.05	-23.97	-26.38	-13.74
Share holders equity per share	40.27	42.34	56.31	63.21	69.07
Interest debt per share	14.13	30.54	30.41	31.37	27.43
Market cap	72.25B	109.74B	156.88B	235.11B	192.46B
Enterprise value	81.2B	111.56B	172.04B	254.7B	206.14B
P/E ratio	27.25	36.48	43.03	36.55	26.7
Price to sales ratio	3.63	6.13	7.04	7.98	6.12
POCF ratio	17.96	27.77	25.27	28.13	22.59
PFCF ratio	21.01	33.09	28.96	33.28	26.12
P/B Ratio	2.56	3.63	3.94	5.21	3.84
PTB ratio	2.56	3.63	3.94	5.21	3.84
EV to sales	4.08	6.23	7.72	8.65	6.55
Enterprise value over EBITDA	17.07	24.2	28.13	25.22	19.22
EV to operating cash flow	20.19	28.23	27.71	30.47	24.2
EV to free cash flow	23.62	33.64	31.76	36.06	27.98
Earnings yield	0.04	0.03	0.02	0.03	0.04
Free cash flow yield	0.05	0.03	0.03	0.03	0.04
Debt to equity	0.35	0.72	0.53	0.49	0.39
Debt to assets	0.2	0.35	0.28	0.27	0.23
Net debt to EBITDA	1.88	0.39	2.48	1.94	1.28
Current ratio	1.47	5.19	1.86	1.43	1.89
Interest coverage	21.63	30.1	15.39	31.37	41.18
Income quality	1.52	1.62	1.7	1.32	1.18
Dividend Yield	0.01	0.01	0	0	0
Payout ratio	0.16	0.25	0.17	0.12	0.11
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.06	0.06	0.06	0.06	0.06
Intangibles to total assets	0.79	0.52	0.74	0.77	0.71
Capex to operating cash flow	-0.15	-0.16	-0.13	-0.15	-0.14
Capex to revenue	-0.03	-0.04	-0.04	-0.04	-0.04
Capex to depreciation	-0.45	-0.53	-0.45	-0.6	-0.52
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	58.55	63.31	80.88	113.15	124.3
ROIC	0.07	0.05	0.06	0.09	0.11
Return on tangible assets	0.26	0.1	0.19	0.34	0.3
Graham Net	-21.76	-12.14	-37.06	-42.77	-31.75
Working capital	2.25B	20.66B	6.4B	3.51B	7.49B
Tangible asset value	-9.35B	-2.18B	-16.93B	-18.85B	-9.96B
Net current asset value	-12.51B	-6.2B	-22.58B	-26.36B	-18.38B
Invested capital	0.35	0.72	0.53	0.49	0.39
Average receivables	3.51B	3.34B	3.62B	4.34B	4.77B
Average payables	1.61B	1.61B	1.78B	2.31B	2.43B
Average inventory	1.88B	1.77B	1.96B	2.53B	2.94B
Days sales outstanding	64.03	65.04	66.25	57.39	57.04
Days payables outstanding	71.16	69.73	76.24	81.53	66.93
Days of inventory on hand	79.35	74.97	85.29	87.81	90.65
Receivables turnover	5.7	5.61	5.51	6.36	6.4
Payables turnover	5.13	5.23	4.79	4.48	5.45
Inventory turnover	4.6	4.87	4.28	4.16	4.03
ROE	0.09	0.1	0.09	0.14	0.14
Capex per share	-0.83	-0.89	-1.12	-1.81	-1.59

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-07-01	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	10.67	10.52	11.48	9.83	9.71
Net income per share	2.31	2.16	3.06	1.99	1.5
Operating cash flow per share	2.75	2.76	3.49	2.67	2.61
Free cash flow per share	2.34	2.38	3.03	2.29	2.15
Cash per share	5.48	7.07	8.22	10.12	11.63
Book value per share	64.12	64.5	68.71	70.58	70.14
Tangible book value per share	-18.69	-15.4	-13.67	-11.44	-9.72
Share holders equity per share	64.12	64.5	68.71	70.58	70.14
Interest debt per share	27.68	26.48	27.08	27.28	27.05
Market cap	187.52B	188.16B	193.46B	183.84B	176.95B
Enterprise value	203.6B	202.26B	207.15B	196.29B	188.25B
P/E ratio	27.91	29.92	21.67	31.7	40
Price to sales ratio	24.19	24.55	23.12	25.65	24.72
POCF ratio	93.76	93.61	76.14	94.42	91.88
PFCF ratio	110.05	108.58	87.46	109.95	111.64
P/B Ratio	4.02	4	3.86	3.57	3.42
PTB ratio	4.02	4	3.86	3.57	3.42
EV to sales	26.27	26.39	24.75	27.39	26.3
Enterprise value over EBITDA	73.5	78.49	91.78	81.75	129.03
EV to operating cash flow	101.8	100.63	81.52	100.82	97.74
EV to free cash flow	119.49	116.71	93.65	117.4	118.77
Earnings yield	0.01	0.01	0.01	0.01	0.01
Free cash flow yield	0.01	0.01	0.01	0.01	0.01
Debt to equity	0.43	0.41	0.39	0.39	0.38
Debt to assets	0.25	0.24	0.23	0.23	0.23
Net debt to EBITDA	5.8	5.47	6.06	5.19	7.75
Current ratio	1.75	1.78	1.89	1.89	2.08
Interest coverage	43.24	47.98	26.44	26.38	13.39
Income quality	1.19	1.28	1.14	1.34	1.74
Dividend Yield	0	0	0	0	0
Payout ratio	0.13	0.13	0.09	0.14	0.2
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.06	0.05	0.05	0.06	0.06
Intangibles to total assets	0.74	0.72	0.71	0.7	0.69
Capex to operating cash flow	-0.15	-0.14	-0.13	-0.14	-0.18
Capex to revenue	-0.04	-0.04	-0.04	-0.04	-0.05
Capex to depreciation	-0.54	-0.51	-0.58	-0.49	-0.61
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.02
Graham number	57.75	55.96	68.8	56.18	48.66
ROIC	0.03	0.02	0.02	0.02	0.01
Return on tangible assets	0.08	0.07	0.09	0.06	0.04
Graham Net	-36.05	-32.89	-31.58	-29.13	-26.94
Working capital	5.67B	6.25B	7.49B	7.8B	9.06B
Tangible asset value	-13.58B	-11.22B	-9.96B	-8.35B	-7.17B
Net current asset value	-21.98B	-19.79B	-18.38B	-17.02B	-15.72B
Invested capital	0.43	0.41	0.39	0.39	0.38
Average receivables	4.47B	4.47B	4.66B	4.62B	4.26B
Average payables	2.39B	2.31B	2.24B	2.19B	2.02B
Average inventory	3.16B	3.25B	3.17B	3.25B	3.28B
Days sales outstanding	52.56	51.78	52.89	54.16	52.8
Days payables outstanding	71.85	64.04	60.24	66.96	56.5
Days of inventory on hand	96.74	94.59	81.6	108.86	91.94
Receivables turnover	1.71	1.74	1.7	1.66	1.7
Payables turnover	1.25	1.41	1.49	1.34	1.59
Inventory turnover	0.93	0.95	1.1	0.83	0.98
ROE	0.04	0.03	0.04	0.03	0.02
Capex per share	-0.41	-0.38	-0.45	-0.38	-0.46

DHR-PB Dividend History

DHR-PB Frequently Asked Questions

What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol DHR-PB

What is Danaher Corporation stock quote today ?

Danaher Corporation stock price is $1261.26 today.

Is Danaher Corporation stock public?

Yes, Danaher Corporation is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 12.97K
Market Capitalization 916.76B
Employee 79K
CEO Mr. Rainer M. Blair
Headquarters Washington,DC,US
IPO Date 2020-05-11
Website https://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.